NO821762L - N-(2-(2-amino-2-fenyletyl)fenyl)-2,2-dimetyl-propanamid og derivater og fremgangsmaate til fremstilling av disse - Google Patents
N-(2-(2-amino-2-fenyletyl)fenyl)-2,2-dimetyl-propanamid og derivater og fremgangsmaate til fremstilling av disseInfo
- Publication number
- NO821762L NO821762L NO821762A NO821762A NO821762L NO 821762 L NO821762 L NO 821762L NO 821762 A NO821762 A NO 821762A NO 821762 A NO821762 A NO 821762A NO 821762 L NO821762 L NO 821762L
- Authority
- NO
- Norway
- Prior art keywords
- approx
- formula
- compound
- phenyl
- mol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- OZTBVKWDFQAZLM-UHFFFAOYSA-N n-[2-(2-amino-2-phenylethyl)phenyl]-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=CC=C1CC(N)C1=CC=CC=C1 OZTBVKWDFQAZLM-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- YXYCLARWQZIXDL-UHFFFAOYSA-N 4-phenyl-4,5-dihydro-1h-1,3-benzodiazepine Chemical class N1C=NC2=CC=CC=C2CC1C1=CC=CC=C1 YXYCLARWQZIXDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 18
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 4
- SMBQBQBNOXIFSF-UHFFFAOYSA-N dilithium Chemical compound [Li][Li] SMBQBQBNOXIFSF-UHFFFAOYSA-N 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- AFDMODCXODAXLC-UHFFFAOYSA-N phenylmethanimine Chemical compound N=CC1=CC=CC=C1 AFDMODCXODAXLC-UHFFFAOYSA-N 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 230000007306 turnover Effects 0.000 claims description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 12
- HXTGGPKOEKKUQO-VQHVLOKHSA-N N-BENZYLIDENEMETHYLAMINE Chemical compound C\N=C\C1=CC=CC=C1 HXTGGPKOEKKUQO-VQHVLOKHSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000012458 free base Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- XCQPQZZKXKILQA-UHFFFAOYSA-N 4-phenyl-3h-1,3-benzodiazepine Chemical class C=1C2=CC=CC=C2NC=NC=1C1=CC=CC=C1 XCQPQZZKXKILQA-UHFFFAOYSA-N 0.000 description 7
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- MQBWNTFLUJEUJX-UHFFFAOYSA-N 2-[2-(methylamino)-2-phenylethyl]aniline;dihydrochloride Chemical compound Cl.Cl.C=1C=CC=CC=1C(NC)CC1=CC=CC=C1N MQBWNTFLUJEUJX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 230000002051 biphasic effect Effects 0.000 description 4
- 239000008241 heterogeneous mixture Substances 0.000 description 4
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 4
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- STDYWHYUOSSCBO-UHFFFAOYSA-N 2,3-dimethyl-4-phenyl-4,5-dihydro-1,3-benzodiazepine Chemical compound C1C2=CC=CC=C2N=C(C)N(C)C1C1=CC=CC=C1 STDYWHYUOSSCBO-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 2
- ZYTSXKGVVRGJIF-UHFFFAOYSA-N 2,2-dimethyl-n-[2-[2-(methylamino)-2-phenylethyl]phenyl]propanamide Chemical compound C=1C=CC=CC=1C(NC)CC1=CC=CC=C1NC(=O)C(C)(C)C ZYTSXKGVVRGJIF-UHFFFAOYSA-N 0.000 description 2
- QWSUPGPRZVRNMD-UHFFFAOYSA-N 2,3-dimethyl-4-phenyl-1,3-benzodiazepine Chemical compound CN1C(C)=NC2=CC=CC=C2C=C1C1=CC=CC=C1 QWSUPGPRZVRNMD-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- XIPFMBOWZXULIA-UHFFFAOYSA-N pivalamide Chemical compound CC(C)(C)C(N)=O XIPFMBOWZXULIA-UHFFFAOYSA-N 0.000 description 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- MPCFUVUJEVJVOE-UHFFFAOYSA-N 2,3-dimethyl-4-phenyl-1,3-benzodiazepine;hydrochloride Chemical compound Cl.CN1C(C)=NC2=CC=CC=C2C=C1C1=CC=CC=C1 MPCFUVUJEVJVOE-UHFFFAOYSA-N 0.000 description 1
- RKGYKBFILSMGSV-UHFFFAOYSA-N 2,3-dimethyl-4-phenyl-4,5-dihydro-1,3-benzodiazepine;hydrochloride Chemical compound Cl.C1C2=CC=CC=C2N=C(C)N(C)C1C1=CC=CC=C1 RKGYKBFILSMGSV-UHFFFAOYSA-N 0.000 description 1
- QETLIJUGLZUEAR-UHFFFAOYSA-N 2-[2-(ethylamino)-2-phenylethyl]aniline Chemical compound C=1C=CC=CC=1C(NCC)CC1=CC=CC=C1N QETLIJUGLZUEAR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- -1 dilithium compound Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26799081A | 1981-05-28 | 1981-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO821762L true NO821762L (no) | 1982-11-29 |
Family
ID=23020992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO821762A NO821762L (no) | 1981-05-28 | 1982-05-27 | N-(2-(2-amino-2-fenyletyl)fenyl)-2,2-dimetyl-propanamid og derivater og fremgangsmaate til fremstilling av disse |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0066773B1 (de) |
| JP (2) | JPS57200342A (de) |
| KR (1) | KR880002290B1 (de) |
| AT (1) | ATE9219T1 (de) |
| CA (1) | CA1182451A (de) |
| DE (1) | DE3260654D1 (de) |
| DK (1) | DK239582A (de) |
| ES (1) | ES8306711A1 (de) |
| FI (1) | FI821872A0 (de) |
| GR (1) | GR76446B (de) |
| NO (1) | NO821762L (de) |
| PT (1) | PT74966B (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES484553A1 (es) * | 1978-10-05 | 1980-05-16 | Hoechst Ag | Un metodo para preparar 4-fenil-1,3-benzodiazepinas |
-
1982
- 1982-05-21 ES ES512430A patent/ES8306711A1/es not_active Expired
- 1982-05-25 AT AT82104546T patent/ATE9219T1/de not_active IP Right Cessation
- 1982-05-25 DE DE8282104546T patent/DE3260654D1/de not_active Expired
- 1982-05-25 EP EP82104546A patent/EP0066773B1/de not_active Expired
- 1982-05-26 GR GR68269A patent/GR76446B/el unknown
- 1982-05-26 KR KR8202329A patent/KR880002290B1/ko active
- 1982-05-26 FI FI821872A patent/FI821872A0/fi not_active Application Discontinuation
- 1982-05-27 PT PT74966A patent/PT74966B/pt unknown
- 1982-05-27 JP JP57088956A patent/JPS57200342A/ja active Granted
- 1982-05-27 NO NO821762A patent/NO821762L/no unknown
- 1982-05-27 CA CA000403887A patent/CA1182451A/en not_active Expired
- 1982-05-27 DK DK239582A patent/DK239582A/da not_active Application Discontinuation
-
1991
- 1991-03-04 JP JP3061022A patent/JPH04217965A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57200342A (en) | 1982-12-08 |
| CA1182451A (en) | 1985-02-12 |
| DE3260654D1 (en) | 1984-10-11 |
| JPH04217965A (ja) | 1992-08-07 |
| DK239582A (da) | 1982-11-29 |
| ES512430A0 (es) | 1983-06-01 |
| PT74966B (en) | 1984-11-26 |
| EP0066773A1 (de) | 1982-12-15 |
| PT74966A (en) | 1982-06-01 |
| FI821872A0 (fi) | 1982-05-26 |
| KR830010050A (ko) | 1983-12-24 |
| GR76446B (de) | 1984-08-10 |
| KR880002290B1 (ko) | 1988-10-22 |
| ES8306711A1 (es) | 1983-06-01 |
| JPH0352453B2 (de) | 1991-08-12 |
| EP0066773B1 (de) | 1984-09-05 |
| ATE9219T1 (de) | 1984-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4861891A (en) | Antidepressant N-substituted nicotinamide compounds | |
| US7459580B2 (en) | Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives | |
| CA2063170A1 (en) | Indole derivatives, preparation processes and medicinal products containing them | |
| NO309718B1 (no) | Fremgangsmåte for fremstilling av mellomprodukter i syntese av benzopyranforbindelser og mellomprodukter i denne fremgangsmåten | |
| CN108373468B (zh) | 一种n-2-吡啶-5-嘧啶甲胺的制备方法 | |
| PL90072B1 (en) | Method for synthesis of optically active lactones[us3876656a] | |
| JPS60231645A (ja) | Ｏ―置換オキシム化合物の合成方法および相当ヒドロキシルアミンｏ―置換化合物への転化方法 | |
| NO821762L (no) | N-(2-(2-amino-2-fenyletyl)fenyl)-2,2-dimetyl-propanamid og derivater og fremgangsmaate til fremstilling av disse | |
| US5250540A (en) | Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments | |
| US4709093A (en) | Method for the preparation of 4-phenyl-1,3-benzodiazepines and precursors thereof | |
| US5349086A (en) | Method for the preparation of 4-phenyl-1,3-benzodiazepins and precursors thereof | |
| US5852194A (en) | N-substituted cis-n-propenyl-acetamides, and process for their preparation | |
| US4374067A (en) | Intermediates for the preparation of 4-phenyl-1,3-benzodiazepins and methods for preparing the intermediates | |
| NO144099B (no) | Dyse for maskinell flammehoevling av enkelte defekter paa overflaten til et metallegeme | |
| US4461728A (en) | Preparation of 4-phenyl-1,3-benzodiazepins | |
| DK156391B (da) | Analogifremgangsmaade til fremstilling af 3-aminopyrrolderivater | |
| SU715020A3 (ru) | Способ получени -трициклических производных азетидина или их оптических изомеров или их солей | |
| SU453843A3 (ru) | Способ получения 3-гуанидиноалкилтиофенов | |
| US5541332A (en) | Chloropyridinium chlorides and process for their preparation | |
| DK158038B (da) | Fremgangsmaade til fremstilling af di-n-propylacetonitril | |
| JP3463937B2 (ja) | ２，３，５，６−テトラクロロピリジンの製造 | |
| US2696488A (en) | 2, 4, 6-tris-(1-piperidyl)-5-benzylpyrimidine and process of preparing same | |
| NO744667L (de) | ||
| CA2000399C (en) | Substituted thienylethylamines and process for their production | |
| Porcs‐Makkay et al. | New synthesis of oxindole‐1‐carboxamides |